Alan Fuhrman

Affiliations

• Chief Financial Officer at Tyra Biosciences Inc. (TYRA), 2024-03-20
• Director at Esperion Therapeutics Inc. (ESPR), 2023-06-16
• Director at Springworks Therapeutics Inc. (SWTX), 2023-05-25
• Director at Checkmate Pharmaceuticals Inc. (CMPI), 2022-05-31
• Director at Loxo Oncology Inc. (LOXO), 2019-02-15
• Chief Financial Officer at Mirna Therapeutics Inc. (MIRN), 2016-03-14
• Chief Financial Officer at Ambit Biosciences Corp (AMBI), 2014-11-12